StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3011% above fair value
$262.21+2.61 (+1.01%)

Close on Nov 16, 2026Market cap $28.85BP/E 26.1Yield –

Quest Diagnostics cash

Cash and short-term investments held at the end of each period.

Quest Diagnostics's cash was $797.00M at Sep 30, 2026. For fiscal 2025 it was $420.00M, down 23.5% from the year before. Over ten years it grew 12.2% a year on average. The highest annual figure on record is $1.19B in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$420.00M-23.5%
FY2024Dec 31, 2024$549.00M-20.0%
FY2023Dec 31, 2023$686.00M+117.8%
FY2022Dec 31, 2022$315.00M-63.9%
FY2021Dec 31, 2021$872.00M-24.7%
FY2020Dec 31, 2020$1.16B-2.9%
FY2019Dec 31, 2019$1.19B+783.0%
FY2018Dec 31, 2018$135.00M-1.5%
FY2017Dec 31, 2017$137.00M-64.3%
FY2016Dec 31, 2016$384.00M+188.7%
FY2015Dec 31, 2015$133.00M-30.7%
FY2014Dec 31, 2014$192.00M+2.7%
FY2013Dec 31, 2013$187.00M-36.8%
FY2012Dec 31, 2012$296.00M+79.4%
FY2011Dec 31, 2011$165.00M-63.3%
FY2010Dec 31, 2010$449.00M-16.0%
FY2009Dec 31, 2009$534.26M+110.4%
FY2008Dec 31, 2008$253.95M+51.5%
FY2007Dec 31, 2007$167.59M+12.0%
FY2006Dec 31, 2006$149.64M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$797.00M+84.5%
Q2 FY2026Jun 30, 2026$626.00M+96.2%
Q1 FY2026Mar 31, 2026$393.00M+109.0%
Q4 FY2025Dec 31, 2025$420.00M-23.5%
Q3 FY2025Sep 30, 2025$432.00M-43.5%
Q2 FY2025Jun 30, 2025$319.00M+17.7%
Q1 FY2025Mar 31, 2025$188.00M-60.3%
Q4 FY2024Dec 31, 2024$549.00M-20.0%
Q3 FY2024Sep 30, 2024$764.00M+434.3%
Q2 FY2024Jun 30, 2024$271.00M+115.1%
Q1 FY2024Mar 31, 2024$474.00M+170.9%
Q4 FY2023Dec 31, 2023$686.00M+117.8%
Q3 FY2023Sep 30, 2023$143.00M-79.6%
Q2 FY2023Jun 30, 2023$126.00M-84.1%
Q1 FY2023Mar 31, 2023$175.00M-75.4%
Q4 FY2022Dec 31, 2022$315.00M-63.9%
Q3 FY2022Sep 30, 2022$700.00M-29.1%
Q2 FY2022Jun 30, 2022$790.00M+41.1%
Q1 FY2022Mar 31, 2022$712.00M-42.1%
Q4 FY2021Dec 31, 2021$872.00M-24.7%
Q3 FY2021Sep 30, 2021$987.00M-38.5%
Q2 FY2021Jun 30, 2021$560.00M-43.3%
Q1 FY2021Mar 31, 2021$1.23B+259.6%
Q4 FY2020Dec 31, 2020$1.16B-2.9%
Q3 FY2020Sep 30, 2020$1.61B+269.8%
Q2 FY2020Jun 30, 2020$988.00M+261.9%
Q1 FY2020Mar 31, 2020$342.00M-26.3%
Q4 FY2019Dec 31, 2019$1.19B+783.0%
Q3 FY2019Sep 30, 2019$434.00M+65.0%
Q2 FY2019Jun 30, 2019$273.00M+106.8%
Q1 FY2019Mar 31, 2019$464.00M+274.2%
Q4 FY2018Dec 31, 2018$135.00M-1.5%
Q3 FY2018Sep 30, 2018$263.00M-24.9%
Q2 FY2018Jun 30, 2018$132.00M-58.0%
Q1 FY2018Mar 31, 2018$124.00M-66.2%
Q4 FY2017Dec 31, 2017$137.00M-64.3%
Q3 FY2017Sep 30, 2017$350.00M–
Q2 FY2017Jun 30, 2017$314.00M–
Q1 FY2017Mar 31, 2017$367.00M–
Q4 FY2016Dec 31, 2016$384.00M–

More Quest Diagnostics figures

See a number that looks wrong?